FindTrial
Sign In

Mechanism of circulating miRNAs in hypertensive cardiac hypertrophy and its predictive value for hypertensive cardiac hypertrophy

Mechanism of miRNA92b in hypertensive cardiac hypertrophy and its predictive value for hypertensive cardiac hypertrophy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018141
Enrollment
Unknown
Registered
2018-09-01
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Case series:Nil

Sponsors

Guangdong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age 18 to 75 years old with a family history of hypertension; 2) patients with essential hypertension; 3) New high blood pressure or high blood pressure has been diagnosed but no antihypertensive drugs have been taken.

Exclusion criteria

Exclusion criteria: 1) secondary hypertension; 2) Hypertensive patients with coronary heart disease and diabetes; 3) Hypertensive patients who are taking or have taken antihypertensive drugs; 4) Hypertensive patients with malignant arrhythmia, moderate to severe valvular disease and congenital heart disease; 5) Hypertensive patients with hyperthyroidism and hypothyroidism; 6) Hypertensive patients with tumor, liver and kidney dysfunction; 7) Hypertensive patients with heart failure; 8) Hypertensive patients with various cardiomyopathy; 9) smokers; 10) Patients who do not cooperate with follow-up and informed consent.

Design outcomes

Primary

MeasureTime frame
Echocardiography;blood lipids;blood pressure;—

Countries

China

Contacts

Public ContactHUANG Yu-qing

Guangdong Provincial Hospital

hyq513@126.com+86 13172054256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026